Introduction
============

The human gastrointestinal (GI) tract is colonized since birth by a complex community of microorganisms that is known to impact its host ([@b22]; [@b56]; [@b59]). The contribution of the GI tract microbiota to converting dietary components into short‐chain fatty acids with significant caloric value, vitamins and other health‐promoting compounds has been well established. However, the interest in determining the microbial composition and its development is growing as it has been shown that the GI tract microbiota has developed intimate relations with its host, communicates with its immune system and can be affected by specific dietary components or bacteria, such as those marketed as prebiotics and probiotics ([@b36]; [@b47]; [@b59]; [@b55]).

The microbial composition of the adult human gut has been subject to multiple studies and found to consist of an individual core that is relatively stable in time ([@b59]). Moreover, phylogenetic analyses of adult subjects have revealed a general core of bacterial representatives shared between multiple individuals of different ages ([@b42]; [@b51]). This was confirmed at the genomic level by recent massive parallel sequence analyses of the adult gut microbiome although at a lower level of depth ([@b24]; [@b52]; [@b41]).

In contrast to the large attention for the adult microbiota, there is only limited information on the development of our intestinal microbe in early life. This is partly due to the large variability in the microbial colonization that is encountered after birth, as was observed in a longitudinal study using culture independent global analyses with a limited set of newborns in the Netherlands ([@b15]). This was confirmed in a more recent comprehensive and longitudinal studies with US babies ([@b37]; [@b13]). It is likely that the first bacterial contact will be different for every individual and in most cases the intestinal inoculum for the newborn baby will derive from the mother. Deep genome sequencing studies of the mother and child intestinal microbiota appear to confirm this ([@b52]). We hypothesize that depending on the infants\' environmental and host factors, certain groups of bacteria will be favoured and dominate their intestinal microbiota. One group of commensal bacteria, those belonging to the genus *Bifidobacterium*, is found among the first colonizers of the baby intestine, notably when breastfed ([@b7]; [@b19]; [@b15]; [@b38]). Remarkably, different results were observed in the recent studies indicating that bifidobacteria are present in only a small fraction of infants or are not numerically dominant in babies ([@b23]; [@b37]). However, this may be due to bias introduced by the methodologies of DNA extraction or PCR detection as discussed recently ([@b45]). Alternatively, geographic origin (EU versus US), diet or both may play a role in explaining this difference that is in particular notable in view of the presumed interactions of bifidobacteria and our immune system ([@b34]; [@b8]). Data on the compositions of bifidobacterial populations in infants show variable results, partly reflecting the high variability between the baby microbiota. Overall, *B. longum*, *B. breve*, *B. infantis* and *B. adolescentis* have been found in faecal samples of healthy human infants ([@b29]; [@b21]; [@b53]). A broader set of species has been described for the 'adult‐like' bifidobacterial microbiota including additional species of *B. catenulatum*,*B. bifidum* and *B. pseudolongum* ([@b29]; [@b20]; [@b53]). Moreover, there are indications for several new *Bifidobacterium* species in the human gut that so far have not been cultured ([@b6]; [@b54]). The development of the infant microbial community from the time of birth to the 'adult‐like' composition often follows the introduction of solid foods after weaning and its timeframe is poorly understood. Similarly, the effect of diet on the composition of the infant microbiota is also controversial. Numerous studies have found a lower abundance of bifidobacteria and a higher abundance of aerobic bacteria in the microbiota of formula‐fed infants relative to breastfed infants ([@b19]; [@b23]; [@b38]), yet other reports have found no such difference ([@b39]). An explanation could be that these studies have to cope with numerous different parameters such as differences between babies, extraction methods, sample storage and detection platforms.

Interestingly, bifidobacteria have been detected in breastmilk samples using culture‐independent molecular techniques ([@b16]; [@b17]; [@b11]). Although it is not clear how translocation of bifidobacteria from intestine to breastmilk occurs within the mother, it has been shown that breastmilk contains similar bacteria both before and after breastfeeding, rendering the possibility of inoculation of the breastmilk by the infant less likely. Recently, it has been suggested that the colonization of breastmilk may take place by transfer of intestinal bacteria within the phagocytosing cells from the mother\'s gut to breastmilk ([@b27]; [@b40]). Interestingly, bifidobacterial translocation has recently been shown to occur after oral administration in a particular mouse model ([@b12]). In addition, DNA from intestinal bifidobacteria was detected in human placenta samples. Although no bifidobacteria could be cultured, this suggests that horizontal transfer of bacterial DNA from mother to fetus may occur via the placenta ([@b46]). These results imply that a constant supply of bifidobacteria to the infant\'s intestine is thus assured during breastfeeding and will affect the development of the intestinal microbiota.

For further studying the impact of bifidobacteria or other bacterial groups, it is essential to have reliable and quantitative identification tools with high discriminating abilities. A variety of culturing‐independent microbial screening and detection techniques have been developed. Small subunit ribosomal DNA (rDNA) sequence analysis via cloning or pyrosequencing ([@b29]; [@b25]; [@b4]), temperature/denaturing gel electrophoresis (D/TGGE) ([@b60]; [@b15]) and terminal‐restriction fragment length polymorphism (T‐RFLP) ([@b59]) are useful for identifying the dominant members of a population and for discovering new rDNA species ([@b33]), but inadequate for detection and quantification of rare species while they all rely on PCR amplifications. Other currently available quantitative techniques, such as fluorescence *in situ* hybridization (FISH) ([@b2]; [@b3]; [@b32]), dot‐blot hybridization ([@b23]) and real‐time PCR ([@b18]; [@b39]), are not easily applied to large numbers of taxonomic groups or also need an amplification reaction. Recently, 16S rRNA‐based phylogenetic microarrays have been developed to study the intestinal microbial ecology of different age groups ([@b37]; [@b59]; [@b10]; [@b42]). Moreover, a variety of genomics approaches including comparative genome hybridization have been developed to study the functionality of bifidobacteria ([@b57]). Previously, we described the development and application of comparative genome hybridization approach involving a bifidobacterial multispecies (BMS)‐microarray platform, consisting of genomic DNA fragments that are specific for *Bifidobacterium* species and phylogenetic groups of bifidobacteria ([@b9]). Here, we expand the use of this BMS‐microarray to analyse complex *Bifidobacterium* communities in faecal samples that were obtained from six healthy human infants that were either breastfed, standard formula‐fed, or fed with probiotic of prebiotic formulas. From every infant 10 faecal samples ranging from the first week to 2 years of age were analysed for their *Bifidobacterium* DNA content and composition. Specific patterns were observed that showed the impact of the diet notably on the development of *B. breve* communities. This proof of principle study illustrates the potential of using comparative genome hybridization in faecal samples and shows population shifts at the strain level obviating the need for cultivation and amplification procedures.

Results
=======

Analysis of the bifidobacterial community based on genomic hybridization patterns
---------------------------------------------------------------------------------

We designed a culture‐independent tool for analysing the composition of bifidobacterial communities within complex microbial samples on species and strain level by generating and mapping of genomic hybridization patterns. This tool is based on a random clone microarray containing total DNA of those bifidobacterial species that have been found in the human intestinal tract. DNA from collected faecal samples was extracted to test the applicability of the microarray platform as a molecular tool in a proof‐of‐principle study ([Fig. 1](#f1){ref-type="fig"}). Faecal samples were obtained from six healthy human infants who received different diets during their weaning period. Two infants were breastfed, two were fed with a standard formula -- one of them received an additional supplement of viable *B. lactis* Bb12 cells, and two were fed with a formula containing a prebiotic mixture of galacto‐ and fructo‐oligosaccharides (GOS and FOS respectively). In order to study the temporal development and changes of the bifidobacterial composition, a total of 10 samples were analysed per infant and the first sample was obtained at day 5 and the final sample at an age of 25 months ([Fig. 1](#f1){ref-type="fig"}). The microarray results show that most faecal samples of each of the infants turned out to be *Bifidobacterium*‐positive ([Fig. 2](#f2){ref-type="fig"}). Furthermore, we generally observed a drop in hybridization signals, in general the majority (over 90%) of the signals disappeared, from the moment the infants reached the age of 1 year. In most cases, this time point correlates with the change of diet. Overall, during the period between 6 and 12 months of age the infants received a mixed diet. This means that next to their weaning they started to ingest solid food. This obviously affects the composition of their intestinal microbiota. To verify whether there was any effect on the total community and that of bifidobacteria in particular, we performed qPCR amplification of strategic phylogenetic groups (see below). In line with the array data the bifidobacteria qPCR values also dropped, indicating that the absolute amount of *Bifidobacterium* DNA was decreased ([Fig. 2](#f2){ref-type="fig"}).

![Schematic sample information overview. A selection of faecal samples collected during the study described by [@b5]).](mbt0004-0417-f1){#f1}

![Heat map visualization of the microarray‐ and qPCR‐based screening of the *Bifidobacterium* composition of faecal samples of six infants who received three different diets ([Fig. 1](#f1){ref-type="fig"}). Time‐course samples are indicated by the age of the infant (D = day, W = week, M = month). The microarray data are presented as the percentage of marker‐clones, per species or species group ([Table 1](#t1){ref-type="table"}), that give a significant hybridization. The percentages are visualized according to the colour‐bar above the heat map. The qPCR results are presented as DNA concentrations (nanograms of DNA per sample) of the different species and visualized according to the colour‐bar above the heat map. The asterisk '\*' indicates data not available.](mbt0004-0417-f2){#f2}

The presented microarray data showed that the samples from two infants who were breastfed for at least 1 year, infants A and B, showed presence of DNA fragments that are highly homologous to *B. breve* DNA ([Fig. 2A and B](#f2){ref-type="fig"}). The DNA samples originating from infants C and D, who were fed a standard formula, showed abundance of bifidobacterial DNA, which was highly homologous to DNA of *B. longum* ssp. *longum* ([Fig. 2C and D](#f2){ref-type="fig"}). Additionally, the samples isolated from the faeces of infant D contained DNA that hybridized also with marker clones for the *B. animalis*/*B. lactis* group. This latter observation is in concordance with the feeding trial of the viable *B. lactis* Bb12 supplement, which started from birth and ended after 12 months. The infants that received a prebiotic mixture showed a shift in the bifidobacterial composition ([Fig. 2E and F](#f2){ref-type="fig"}). This shift was observed between week 8 and week 12. Interestingly, this correlates with the start of the prebiotic mixture feeding trial at week 10. From week 12, DNA homologous to *B. breve* becomes more abundant whereas DNA of other *Bifidobacterium* species disappears ([Fig. 2](#f2){ref-type="fig"}).

Validation by qPCR analysis
---------------------------

To support the microarray results and to gain information on the quantitative amounts of *Bifidobacterium* species present in the faecal samples, a series of qPCR analyses were performed as summarized in heatmaps ([Fig. 2](#f2){ref-type="fig"}). Although it is a totally different approach based on specific ribosomal RNA sequences, the qPCR results were in line with the data obtained by the microarray platform. This means that when the microarray detected DNA homologous to the DNA of a specific *Bifidobacterium* species, the qPCR platform detected the presence of DNA originating from that same species. Differences between qPCR and microarray results can be explained by the fact that qPCR is a more quantitative measurement than the microarray platform. The dynamic ranges of the platforms are quite comparable and the microarray platform could detect as little as 0.1% of the DNA isolated from the faecal samples (data not shown). However, the microarray platform provided detailed information on the genetic content and shifts within one species or phylogenetic group of bifidobacteria that goes beyond the detection capacity of qPCR (see below).

Screening for genomic shifts within one *Bifidobacterium* species group in time
-------------------------------------------------------------------------------

Due to its high‐resolution output, the microarray platform does not only give information on shifting of bifidobacterial species but also enables to zoom in at the strain level. Comparison of hybridization signals results in detailed information on the shifting of bifidobacterial genomic material even within a single species, which suggests succession of strains. Using this principle, we analysed the DNA samples and zoomed in on the composition of the *B. breve* species group of each infant ([Fig. 3](#f3){ref-type="fig"}). We concluded that every infant contained a unique *B. breve* community, with the exception of the faecal samples of infants C and D that did not contain any *B. breve* related DNA ([Fig. 3](#f3){ref-type="fig"}). This was observed earlier as visualized in [Fig. 2](#f2){ref-type="fig"}. The *B. breve* populations were generally stable in time. Concentrating on the differential markers within the *B. breve* set, we detected a shift in time in the hybridization pattern of infant B ([Fig. 3](#f3){ref-type="fig"}). We conclude that the *B. breve* group of this infant gained and lost specific *B. breve*‐specific DNA fragments at approximately 12 weeks of development. However, a core *B. breve* genome seemed to be present in both situations. We hypothesize that a *B. breve* population always contains the *B. breve* core genome plus *B. breve* strain‐specific genomic fragments. To gain more insight in the genes encoded by these fragments we have sequenced a subset of 11 genomic *B. breve* markers ([Fig. 4](#f4){ref-type="fig"}). Fragments 1 and 2 are present in all samples that are known to contain *B. breve*, based on the qPCR results. We suggest that they belong to the *B. breve*'core‐genome' ([Fig. 4](#f4){ref-type="fig"}). Fragments 5 and 6 ([Fig. 4](#f4){ref-type="fig"}) seem to appear in the later time samples in infant B but were present in all time samples of infant A. These fragments must be strain‐specific. The best [blastx]{.smallcaps} hits all showed more than 98% sequence homology to genes in the published *B. breve* DSM 20213 genome (ACCG02000000) and had *E*‐values close to zero. Fragments 9, 10 and 11 are not specific for any of the faecal isolates but only for the *B. breve* type strain that was used for defining the species‐specific marker fragments ([Table 1](#t1){ref-type="table"}). Inspection of the other fragments showed them to code for stress‐related functions, proteins involved in cell envelope integrity or hypothetical proteins. Remarkably, fragments 1 and 4 coded for a potential sugar‐specific PTS transport component and a beta‐glycosidase that were both almost or completely absent in the babies that received standard formula. It is tempting to speculate that the used‐formula product lacks the sugars present in the breastmilk and prebiotic FOS/GOS mixture that was used to feed the other babies.

![Hierarchical clustering (Pearson correlation) of the hybridization signals of genomic DNA fragments within the *B. breve* marker set for all faecal samples in time‐course order. Signal intensities are indicated by a black‐white colour gradient. On the *X*‐axis the sample codes are presented (D = day; W = week; M = month). Samples from one infant are highlighted by the bars above the codes as indicated in [Fig. 1](#f1){ref-type="fig"}.](mbt0004-0417-f3){#f3}

![Hybridization signal intensities and 'best [blastx]{.smallcaps} hits' (\> 98% homology) of a subset of 11 *B. breve* markers that have been sequenced are visualized for each marker fragment. The sample order is similar to the order in [Fig. 3](#f3){ref-type="fig"}. Marker fragments 1 and 2 can be described as *B. breve* core genome whereas marker fragments 3--11 show to be strain‐specific.](mbt0004-0417-f4){#f4}

###### 

Marker groups, the number of marker clones they include and the strains of origin.

  Marker group names               Strains of origin                  Number of marker clones                                                                                                                                                                                                                                                                                                                                       
  -------------------------------- ---------------------------------- ---------------------------------- ---------------------------------- ---------------------------------- ---------------------------------- ---------------------------------- ---------------------------------- ---------------------------------- ---------------------------------- ---------------------------------- ---------------------------------- ------
  B. adolescentis                  [\*](#t1n1){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                                 141
  B. animalis/B. lactis                                               [\*](#t1n1){ref-type="table-fn"}   [\*](#t1n1){ref-type="table-fn"}                                                                                                                                                                                                                                                                                           68
  B. bifidum                                                                                                                                [\*](#t1n1){ref-type="table-fn"}                                                                                                                                                                                                                                                        49
  B. breve                                                                                                                                                                     [\*](#t1n1){ref-type="table-fn"}   [\*](#t1n1){ref-type="table-fn"}                                                                                                                                                                                  227
  B. breve/B. infantis                                                                                                                                                         [\*](#t1n1){ref-type="table-fn"}   [\*](#t1n1){ref-type="table-fn"}   [\*](#t1n1){ref-type="table-fn"}                                                                                                                                               129
  B. breve/B. infantis/B. longum                                                                                                                                               [\*](#t1n1){ref-type="table-fn"}   [\*](#t1n1){ref-type="table-fn"}   [\*](#t1n1){ref-type="table-fn"}   [\*](#t1n1){ref-type="table-fn"}   [\*](#t1n1){ref-type="table-fn"}                                                                         204
  B. infantis/B. longum                                                                                                                                                                                                                              [\*](#t1n1){ref-type="table-fn"}   [\*](#t1n1){ref-type="table-fn"}   [\*](#t1n1){ref-type="table-fn"}                                                                         127
  B. longum                                                                                                                                                                                                                                                                             [\*](#t1n1){ref-type="table-fn"}   [\*](#t1n1){ref-type="table-fn"}                                                                         167
  B. catenulatum                                                                                                                                                                                                                                                                                                                                              [\*](#t1n1){ref-type="table-fn"}                                      1348
  B. pseudolongum                                                                                                                                                                                                                                                                                                                                                                                [\*](#t1n1){ref-type="table-fn"}   103

The asterisk '' indicates which marker groups are based on which strains.

Discussion
==========

In this study we showed that comparative genome hybridization using a bifidobacterial mixed species microarray platform can be applied as a culture‐independent tool to analyse the composition and development of *Bifidobacterium* populations in faecal samples from human infants. Using this microarray platform we obtained a high‐resolution data output, which enabled us to zoom in towards the species and strain level of the bifidobacterial population. An advantage of our approach is that we did not need to enrich our DNA samples for bifidobacterial DNA. While qPCR is more quantitative than the microarray platform, both approaches have similar sensitivity and dynamic range. Our observations showed differences in composition of faecal bifidobacterial communities in developing infants. As this study serves as a proof of principle, we want to stress that these results are based on a limited set of infants. Nevertheless, the data suggest an obvious link between diet and *Bifidobacterium* population. Moreover, our results indicate that the prebiotic formula applied in this study affects the composition of the intestinal *Bifidobacterium* population. As indicated previously ([@b5]), the composition of the infants who received the GOS/FOS mixture seems to be shifted towards the direction of the *Bifidobacterium* community as found in infants who were breastfed, in contrast to the standard‐formula diet ([Fig. 2](#f2){ref-type="fig"}). In line with other studies no *B. pseudolongum* homologous DNA was detected in the faecal samples tested ([@b7]; [@b30]; [@b19]; [@b15]; [@b14]; [@b18]). In conclusion, we expect that in combination with a large well‐defined sample set, the described comparative hybridization approach with the microarray platform will contribute to a better understanding of our intestinal microbial ecology. Furthermore, this application could be combined with next‐generation sequencing to generate a pan‐genomic *Bifidobacterium* screening tool.

Experimental procedures
=======================

Sample collection, DNA isolation and qPCR analysis
--------------------------------------------------

A selection of faecal samples, collected during the study described by [@b5]), formed the basis of this study ([@b5]). Detailed information on the samples is visualized in [Fig. 1](#f1){ref-type="fig"}.

For the total DNA isolation from faecal samples, a 96‐well plate (Axygen, VWR International BV, Amsterdam, NL, USA) was filled with 250 µl 0.1 mm zirconium beads (Brunschwig Chemie BV, Amsterdam, NL, USA) washed in lysis buffer without detergents (Agowa GmbH, Berlin, D), 200 µl phenol solution (Tris pH 8.0) and 250 µl lysis buffer without detergents (Agowa GmbH, Berlin, D). Subsequently, per well a volume of a fully loaded inoculation loop (Greiner Bio One, Alphen a/d Rijn, NL), resembling 10 µl of faecal sample, was added to the mixture. After 2 min of bead beating (Mini Beadbeater, Biospec Products, Lab Services BV, Breda, NL, USA), the plate was cooled on ice. Then the plate was centrifuged for 10 min at 1700 *g* and 20°C. The supernatant, about 175 µl, was transferred into a 0.5 ml 96 wells plate (Axygen, VWR International BV, Amsterdam, NL, USA) and 100 µl phenol solution (in Tris pH 8.0) was added. After 10 min of centrifuging at 1700 *g* and 20°C the supernatant, per well approximately 150 µl, was transferred into a 96‐well PCR plate (Bioplastics, Landgraaf, NL, USA). The DNA was extracted by magnetic beads using the Agowa DNA extraction kit (<http://www.lgc.co.uk/>) according to the protocol supplied by the manufacturer. The supernatant, containing the DNA, was stored at −20°C.

qPCR analysis was performed as described by [@b18]). Finally, the qPCR data were visualized using TIGR MeV 3.1 software (<http://www.tm4.org/mev.html>).

Array design and construction
-----------------------------

A genomic library was constructed from seven strains representing seven different *Bifidobacterium* species as described previously ([@b9]) with the difference that the *B. pseudolongum* library has been replaced by two single strain libraries of *B. breve* LMG 13208^T^ (BRE) and *B. catenulatum* LMG 11043^T^ (CAT). These strains were obtained from the Belgian Co‐ordinated Collections of Microorganisms (BCCM), Gent, B. In total this microarray contains four different libraries. The libraries of BRE and CAT were constructed from genomic material and contain 2000 clones, which represent about 85% (calculated according to [@b1]) of the genomes. Except for the fragmentation of the total DNA of *B. catenulatum*, the construction of the BRE and the CAT libraries was performed as previously described in [@b9]). The *B. catenulatum* DNA was fragmentized by blunt‐ended partial digestion using HaeIII (New England Biolabs, Westburg BV, Leusden, NL, USA). A volume of 10 µl total DNA (∼600 ng µl^−1^) was combined with 9 µl reaction buffer 2 (New England Biolabs, Westburg BV), 1 µl HaeIII, and 80 µl milli Q water and subsequently incubated at 37°C for 20 min. After incubation the DNA samples were loaded in 1.5% agarose/1× TAE gel. Samples sized from 1 to 2 kb were isolated from gel during electrophoresis using Takara Recochips (TaKaRa Bio, Lonza Verviers, Verviers, BE, USA) according to the protocol provided by the supplier. Due to the blunt‐end restriction of HaeIII, end‐repair as described in [@b9]) was not necessary.

Fluorescent labelling and hybridization
---------------------------------------

Total DNA samples were labelled by random prime labelling. A volume of 1 µl DNA sample was diluted in 4.25 µl H~2~O and mixed with 5 µl of 2.5× random primer (BioPrime Kit, Invitrogen, Breda, NL, USA). The mixture was incubated at 96°C for 5 min. After cooling on ice, the samples were shortly centrifuged at maximum speed in an eppendorf centrifuge. Subsequently, the following components were added while the samples were kept in ice: 0.25 µl 50× AminoAcid‐dNTP mix (AA‐dNTP) (Invitrogen), 1.75 µl milliQ and 0.25 µl Klenow fragment (Invitrogen). After addition the samples were incubated at 37°C for 1.5 h for amplification. Unincorporated aa‐dUTP and free amines were removed using QIAqiuck columns following the protocol described by the supplier (QIAgen Benelux BS, Venlo, NL, USA). For this purpose, five times the reaction volume of PB buffer (QIAgen supplied) was added to the samples and the mixture was transferred to a QIAqiuck Spin Column that was centrifuged at 20 000 *g* for 1 min. To increase the binding efficiency, the flow‐through was reloaded and the column was centrifuged again at 20 000 *g* for 1 min and the flow through was discarded. To elute the DNA samples from the columns they were first washed separately with 500 µl of 80% ethanol and then eluted with 30 µl of milliQ H~2~O, a step that was repeated twice as described by the manufacturer (Qiagen Benelux BS, Venlo, NL, USA). The elutate was dried at high temperature in a speed vac for about 15--30 min. For coupling of the Cy Dye Esters to the aa‐cDNA, the dried cDNA samples were dissolved in 4.5 µl 0.1 M sodium carbonate buffer (Na~2~CO~3~), pH 9.0 during 10 min at room temperature while mixed a few times. Subsequently, 4.5 µl of the appropriate NHS‐ester Cy Dye (Amersham, Piscataway, USA) was added. This reaction mix was incubated for 1 h at room temperature in the dark. After incubation 10 µl of milliQ H~2~O was added and the samples were centrifuged shortly. To remove the unincorporated dyes we used Autoseq G50 (Amersham, Piscataway, USA) columns according to the protocol supplied by the manufacturer.

DNA microarrays were prehybridized for 45 min at 42°C in prehybridization solution (1% bovine serum albumin, 5× SSC and 0.1% SDS). Co‐hybridizations of labelled DNA samples were performed overnight at 42°C in 40 µl Easyhyb buffer (Roche, Almere, NL, USA) according to the manufacturer\'s protocol. Slides were washed twice in 1× SSC, 0.2% SDS at 37°C, once in 0.5× SSC, and twice in 0.2× SSC at RT and dried with N~2~‐flow.

Microarray scan‐image and quality analysis were performed as described previously ([@b9]).

Diagnostic clone selection, visualization and clustering analysis
-----------------------------------------------------------------

For the selection of diagnostic clones we normalized the obtained hybridization data as described previously ([@b9]). For each *Bifidobacterium* species we defined diagnostic clones. A diagnostic clone has a 'high homology' classification for a specific *Bifidobacterium* species and a 'low homology' classification for all other species. Due to the genetic variation between species and the different sizes of the libraries printed on the array the numbers of markers vary per species or species group. The number of marker clones for every species or group of species is listed in [Table 1](#t1){ref-type="table"}.

For visualization of the produced hybridization values, the data were converted into percentages of marker clones that show significant hybridization signals ([@b9]). This was performed for every marker group on the microarray ([Table 1](#t1){ref-type="table"}). The percentages give an indication for the rate of similarity of the genomic DNA fragments for each *Bifidobacterium* group, present in the total DNA sample isolated from the faecal sample. Finally, these data were visualized using TIGR MeV 3.1 software (<http://www.tm4.org/mev.html>).

The hierarchical clustering of untreated Cy5 signal intensity data, based on a Pearson correlation, was performed and visualized with TIGR MeV 3.1 software (<http://www.tm4.org/mev.html>).

Sequencing of DNA fragments
---------------------------

Plasmid isolation, purification of PCR products and high‐throughput sequencing were performed by GATC Biotech AG, Konstanz, Germany ([http://www.gatc‐biotech.com](http://www.gatc‐biotech.com)). Sequences were compared with public databases by using [blastx]{.smallcaps} and [blastn]{.smallcaps}. [blast]{.smallcaps} analyses were performed against all sequenced genomes in the database using the NCBI website (<http://www.ncbi.nlm.nih.gov>/).
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